Formac Pharmaceuticals Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Grant
  • Investors
  • 6

Formac Pharmaceuticals General Information

Description

Developer of drugs designed to focus on the formulation of poorly soluble active pharmaceutical ingredients. The company's drugs are made by using unique mesoporous silica materials that help in oral formulations of small organic drug compounds to enhance the oral bioavailability of poorly water-soluble active pharmaceutical ingredients, enabling physicians to overcome solubility-limited bioavailability.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Drug Delivery
Primary Office
  • Gaston Geenslaan 2
  • 3001 Heverlee
  • Belgium
+32 016 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Formac Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 04-May-2015 00.00 Completed Generating Revenue
3. Grant 18-Mar-2015 0000 00.00 Completed Generating Revenue
2. Early Stage VC 10-Apr-2009 $3M $5.3M 00.000 Completed Startup
1. Early Stage VC 07-Nov-2007 $2.3M $2.3M 00.000 Completed Startup
To view Formac Pharmaceuticals’s complete valuation and funding history, request access »

Formac Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class B 0,000,000 00.00 00.00 00 00.00 00.000
Class H 000,000 00.00 00.00 00 00.00 00.000
Class F 000,000 00.00 00.00 00 00.00 00.000
Class E 000,000 00.00 00.00 00 00.00 00.000
Class D 000,000 00.00 00.00 00 00.00 00.000
Class C 561,487 $1.33 $1.33 1x $1.33 3.53%
Class B 1,590,469 $1.33 $1.33 1x $1.33 5.71%
To view Formac Pharmaceuticals’s complete cap table history, request access »

Formac Pharmaceuticals Executive Team (6)

Name Title Board Seat Contact Info
Guy Van den Mooter Co-Founder, Chief Scientific Officer & Board Member
Johan Martens Co-Founder
You’re viewing 2 of 6 executive team members. Get the full list »

Formac Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Formac Pharmaceuticals Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
Life Sciences Research Partners Not-For-Profit Venture Capital Minority 000 0000 000000 0
Allegro Investment Fund Venture Capital Minority 000 0000 000000 0
Hunza Ventures Venture Capital Minority 000 0000 000000 0
KU Leuven Research & Development Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »